APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo by Liddament, Mark T., Brown, William L., Schumacher, April J., Harris, Reuben S.

Get full text

Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies by Panagides, Nadya, Zacchi, Lucia F., De Souza, Mitchell J., Morales, Rodrigo A. V., Karnowski, Alexander, Liddament, Mark T., Owczarek, Catherine M., Mahler, Stephen M., Panousis, Con, Jones, Martina L., Fercher, Christian

Get full text

Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold by Steemson, John D, Baake, Matthias, Rakonjac, Jasna, Arcus, Vickery L, Liddament, Mark T

Get full text

The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain by Haché, Guylaine, Liddament, Mark T., Harris, Reuben S.

Get full text

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain by Wheatley, Adam K., Pymm, Phillip, Esterbauer, Robyn, Dietrich, Melanie H., Lee, Wen Shi, Drew, Damien, Kelly, Hannah G., Chan, Li-Jin, Mordant, Francesca L., Black, Katrina A., Adair, Amy, Tan, Hyon-Xhi, Juno, Jennifer A., Wragg, Kathleen M., Amarasena, Thakshila, Lopez, Ester, Selva, Kevin J., Haycroft, Ebene R., Cooney, James P., Venugopal, Hariprasad, Tan, Li Lynn, O Neill, Matthew T., Allison, Cody C., Cromer, Deborah, Davenport, Miles P., Bowen, Richard A., Chung, Amy W., Pellegrini, Marc, Liddament, Mark T., Glukhova, Alisa, Subbarao, Kanta, Kent, Stephen J., Tham, Wai-Hong

Get full text

Higher Binding Affinity and in vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab by Liddament, Mark, Husten, Jean, Estephan, Tanya, Laine, David, Mabon, David, Pukac, Laurie, Lyons, Jacquelyn, Clarke, Adam W, Doyle, Anthony

Get full text